Showing posts with label Sticking Points in Compounding Talks Reflect Long-Held FDA Frustrations. Show all posts
Showing posts with label Sticking Points in Compounding Talks Reflect Long-Held FDA Frustrations. Show all posts

Monday, September 16, 2013

Sticking Points in Compounding Talks Reflect Long-Held FDA Frustrations--




House and Senate aides negotiating compounding pharmacy legislation are quibbling over what volume of interstate commerce by compounders should trigger mandatory FDA oversight, and how that volume should be measured.